Lucky for some: the 13th LCA gene

Article

A new gene has been discovered which, when mutated, causes Leber's congenital amaurosis (LCA), a common form of inherited blindness in babies.

A new gene has been discovered which, when mutated, causes Leber's congenital amaurosis (LCA), a common form of inherited blindness in babies, according to a report in the June issue of Nature Genetics.

The gene (LCA5), discovered by researchers from the University of Leeds, UK is the thirteenth gene to be linked to LCA and is involved in the production of lebercilin, an essential component of photoreceptors in the retina. Although lebercilin is also found in other tissues, mutations in the LCA5 gene only appear to cause defects in the retina.

These mutations are relatively rare as LCA5 is a recessive gene, which means a child would need to be carrying two copies of it to develop LCA; one from each parent. The disorder is more common, however, in populations where marriage to first and second cousins are common.

Clinical trials, which are being run by scientists at Moorfields Eye Hospital, London, UK are already underway involving the injection of genes into the eyes of patients with LCA to help restore their sight.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.